Leveraging artificial intelligence-powered stochastic methods for clinical data review represents a significant leap beyond ...

For AI to truly improve and standardize healthcare delivery, we must confront a fundamental issue—the limited and often ...

Connected and multimodal data bring together diverse datasets such as clinical trial results, patient demographics, claims ...

Icon has begun the integration of Medidata Clinical Data Studio into its clinical studies. This development makes Icon the ...

Biomea Fusion (BMEA) announced the presentation of preclinical and clinical data from studies assessing icovamenib at the ...

The firm's next-generation pancreatic cancer test looks for five biomarkers that are indicative of early-stage disease.

Marengo Therapeutics, Inc., a clinical-stage biotechnology company pioneering novel approaches for precision immunotherapy in oncology and autoimmune diseases, will present updated clinical and ...

The phase III trial COURAGE-ALS of investigational reldesemtiv, a fast skeletal troponin activator, did not meet its primary ...

Oral presentation to highlight preclinical data further supporting combination of KO-2806 with TKIs in ccRCC –– Company expects to present data ...

Pharmaceuticals announced updated clinical data from Part 1b of the ongoing DENALI clinical trial of azenosertib in patients ...

Evaxion will present new biomarker and immune data obtained from the ongoing phase 2 trial. These will further add to EVX-01’s already strong clinical data package.

Avant Technologies Inc. (OTCQB:AVAI) (”Avant” or the “Company”), and its partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease ...